Ascariasis is still very prevalent; one billion people are infected all around the world. In rural areas, severe ascariasis impairs the immune responses to natural infections and vaccination programs. However, in urbanized areas, improved hygiene conditions and periodic anthelmintic treatments have led to light forms of ascariasis, where parasite-induced immunosuppressive effects are surpassed by the immunostimulating effects of the infection. During the last years, the clinical impact of this type of ascariasis on allergic diseases, especially asthma, has been well documented, and it is currently accepted that this relationship should be considered when analyzing allergy prevalence in tropical and temperate countries. This review focuses on the emerging evidence that supports the stimulatory effects of ascariasis on the allergic responses and its clinical importance. Advances on the role of type 2 innate lymphoid cells (ILC2) in helminth immunity and allergy pathogenesis as well as new genetic findings supporting the links between helminthiases and allergy are discussed. We show that ascariasis, beyond its known effects on human health, is able to modify the natural history of asthma, increasing Th2 responses and IgE synthesis to cross-reactive and speciesspecific mite allergens, being a risk factor for asthma and asthma severity.